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1. Background and Objectives 3. Results  
Atrial Fibrillation (AF) is a common heart arrhythmia 
encountered in practice and a major risk factor for 
stroke, contributing to one in five strokes1,2.  In 
England, it has been estimated to affect 1.36 million 
people with half a million currently living with the 
condition undetected3.   
 
As part of the Global AF awareness week (21st to 27th 
November 2016), International Pharmacists for 
Anticoagulation Care Taskforce (iPACT) created a 
partnership with Atrial Fibrillation Association (AFA) to 
test a model where pharmacists across the globe 
become actively involved in raising AF awareness and 
provide pulse rhythm checks amongst the general 
population.   
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A cross sectional study conducted by pharmacists 
across five countries: Canada, New Zealand, Portugal, 
Spain and England, during 21st to 27th  November 2016. 
 
Primary care pharmacists from Southwark Clinical 
Commissioning Group organised a one day AF pulse 
awareness event as part of the global campaign at the 
workplace. 
 
 
     
 
 
Data are available from the Southwark event, during 
which 182 individuals were shown how to check their 
own pulse rhythm, educated and screened for AF.   The 
outcome of the screening is summarised in figure 2.  
Those with an AF or unclassified result were provided 
with a copy of their ECG by e-mail and were referred to 
their physician. 
 
 
 
 
 
 
 
 
 Table 1. Characteristics of  individuals (n=182) 
Age  - years 
• Mean                                                             47 
• Range                                                            21-72 
 
Female sex – number (%)                              105 (58%)  
 
Heart rate – bpm 
• Mean                                                             79 
• Range                                                            51-128    
                                   
Figure 2. Outcome of pulse rhythm check using a single lead handheld AF 
detection device  
The rate of AF detection during the one day event  
substantiates results of a recent meta-analysis: the 
number needed to screen to detect one individual with 
undiagnosed AF for general population is 1004.   
 
For a successful campaign, pharmacists require 
adequate training on AF, on performing manual pulse 
rhythm checks and using detection devices. 
 
AF awareness campaigns undertaken by pharmacists in 
primary care could make a major contribution to 
addressing undiagnosed AF across the globe.   
 
 
 Figure 1. Summary of steps for AF awareness campign 
